Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action

Detalhes bibliográficos
Autor(a) principal: Ribeiro T.
Data de Publicação: 2017
Outros Autores: Lemos F., Preto M., Azevedo J., Sousa M.L., Leão P.N., Campos A., Linder S., Vitorino R., Vasconcelos V., Urbatzka R.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/120516
Resumo: Portoamides are cyclic peptides produced and released by the cyanobacterial strain Phormidium sp. presumably to interfere with other organisms in their ecosystems ("allelopathy"). Portoamides were previously demonstrated to have an antiproliferative effect on human lung carcinoma cells, but the underlying mechanism of this activity has not been described. In the present work, the effects of portoamides on proliferation were examined in eight human cancer cell lines and two non-carcinogenic cell lines, and major differences in sensitivities were observed. To generate hypotheses with regard to molecular mechanisms of action, quantitative proteomics using 2D gel electrophoresis and MALDI-TOF/TOF were performed on the colon carcinoma cell line HT-29. The expression of proteins involved in energy metabolism (mitochondrial respiratory chain and pentose phosphate pathway) was found to be affected. The hypothesis of altered energy metabolism was tested in further experiments. Exposure to portoamides resulted in reduced cellular ATP content, likely due to decreased mitochondrial energy production. Mitochondrial hyperpolarization and reduced mitochondrial reductive capacity was observed in treated cells. Furthermore, alterations in the expression of peroxiredoxins (PRDX4, PRDX6) and components of proteasome subunits (PSB4, PSA6) were observed in portoamide-treated cells, but these alterations were not associated with detectable increases in oxidative stress. We conclude that the cytotoxic activity of portoamides is associated with disturbance of energy metabolism, and alterations in mitochondrial structure and function. © 2017 Ribeiro et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
id RCAP_10dc53e69d7f73efcdb93a73c516d4d1
oai_identifier_str oai:repositorio-aberto.up.pt:10216/120516
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of actionadenosine triphosphateantineoplastic agentpentose phosphateperoxiredoxin 4peroxiredoxin 6portoamide Aportoamide Bproteasomeprotein PSB 4protein PSB 6unclassified drugadenosine triphosphateamideantineoplastic activityArticlecancer cell linecell proliferationcell structurecontrolled studydrug cytotoxicitydrug mechanismdrug sensitivityenergy metabolismHT-29 cell linehumanhuman cellhyperpolarizationmatrix assisted laser desorption ionization time of flight mass spectrometrymitochondrial respirationnonhumanoxidative stressprotein expressionrespiratory chainmatrix-assisted laser desorption-ionization mass spectrometrymetabolismmitochondrionneoplasmpathologyproteomicstumor cell lineAdenosine TriphosphateAmidesCell Line, TumorEnergy MetabolismHumansMitochondriaNeoplasmsOxidative StressProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationPortoamides are cyclic peptides produced and released by the cyanobacterial strain Phormidium sp. presumably to interfere with other organisms in their ecosystems ("allelopathy"). Portoamides were previously demonstrated to have an antiproliferative effect on human lung carcinoma cells, but the underlying mechanism of this activity has not been described. In the present work, the effects of portoamides on proliferation were examined in eight human cancer cell lines and two non-carcinogenic cell lines, and major differences in sensitivities were observed. To generate hypotheses with regard to molecular mechanisms of action, quantitative proteomics using 2D gel electrophoresis and MALDI-TOF/TOF were performed on the colon carcinoma cell line HT-29. The expression of proteins involved in energy metabolism (mitochondrial respiratory chain and pentose phosphate pathway) was found to be affected. The hypothesis of altered energy metabolism was tested in further experiments. Exposure to portoamides resulted in reduced cellular ATP content, likely due to decreased mitochondrial energy production. Mitochondrial hyperpolarization and reduced mitochondrial reductive capacity was observed in treated cells. Furthermore, alterations in the expression of peroxiredoxins (PRDX4, PRDX6) and components of proteasome subunits (PSB4, PSA6) were observed in portoamide-treated cells, but these alterations were not associated with detectable increases in oxidative stress. We conclude that the cytotoxic activity of portoamides is associated with disturbance of energy metabolism, and alterations in mitochondrial structure and function. © 2017 Ribeiro et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Public Library of Science20172017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/120516eng1932620310.1371/journal.pone.0188817Ribeiro T.Lemos F.Preto M.Azevedo J.Sousa M.L.Leão P.N.Campos A.Linder S.Vitorino R.Vasconcelos V.Urbatzka R.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T15:37:47Zoai:repositorio-aberto.up.pt:10216/120516Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:28:12.024024Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
title Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
spellingShingle Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
Ribeiro T.
adenosine triphosphate
antineoplastic agent
pentose phosphate
peroxiredoxin 4
peroxiredoxin 6
portoamide A
portoamide B
proteasome
protein PSB 4
protein PSB 6
unclassified drug
adenosine triphosphate
amide
antineoplastic activity
Article
cancer cell line
cell proliferation
cell structure
controlled study
drug cytotoxicity
drug mechanism
drug sensitivity
energy metabolism
HT-29 cell line
human
human cell
hyperpolarization
matrix assisted laser desorption ionization time of flight mass spectrometry
mitochondrial respiration
nonhuman
oxidative stress
protein expression
respiratory chain
matrix-assisted laser desorption-ionization mass spectrometry
metabolism
mitochondrion
neoplasm
pathology
proteomics
tumor cell line
Adenosine Triphosphate
Amides
Cell Line, Tumor
Energy Metabolism
Humans
Mitochondria
Neoplasms
Oxidative Stress
Proteomics
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
title_short Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
title_full Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
title_fullStr Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
title_full_unstemmed Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
title_sort Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
author Ribeiro T.
author_facet Ribeiro T.
Lemos F.
Preto M.
Azevedo J.
Sousa M.L.
Leão P.N.
Campos A.
Linder S.
Vitorino R.
Vasconcelos V.
Urbatzka R.
author_role author
author2 Lemos F.
Preto M.
Azevedo J.
Sousa M.L.
Leão P.N.
Campos A.
Linder S.
Vitorino R.
Vasconcelos V.
Urbatzka R.
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ribeiro T.
Lemos F.
Preto M.
Azevedo J.
Sousa M.L.
Leão P.N.
Campos A.
Linder S.
Vitorino R.
Vasconcelos V.
Urbatzka R.
dc.subject.por.fl_str_mv adenosine triphosphate
antineoplastic agent
pentose phosphate
peroxiredoxin 4
peroxiredoxin 6
portoamide A
portoamide B
proteasome
protein PSB 4
protein PSB 6
unclassified drug
adenosine triphosphate
amide
antineoplastic activity
Article
cancer cell line
cell proliferation
cell structure
controlled study
drug cytotoxicity
drug mechanism
drug sensitivity
energy metabolism
HT-29 cell line
human
human cell
hyperpolarization
matrix assisted laser desorption ionization time of flight mass spectrometry
mitochondrial respiration
nonhuman
oxidative stress
protein expression
respiratory chain
matrix-assisted laser desorption-ionization mass spectrometry
metabolism
mitochondrion
neoplasm
pathology
proteomics
tumor cell line
Adenosine Triphosphate
Amides
Cell Line, Tumor
Energy Metabolism
Humans
Mitochondria
Neoplasms
Oxidative Stress
Proteomics
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
topic adenosine triphosphate
antineoplastic agent
pentose phosphate
peroxiredoxin 4
peroxiredoxin 6
portoamide A
portoamide B
proteasome
protein PSB 4
protein PSB 6
unclassified drug
adenosine triphosphate
amide
antineoplastic activity
Article
cancer cell line
cell proliferation
cell structure
controlled study
drug cytotoxicity
drug mechanism
drug sensitivity
energy metabolism
HT-29 cell line
human
human cell
hyperpolarization
matrix assisted laser desorption ionization time of flight mass spectrometry
mitochondrial respiration
nonhuman
oxidative stress
protein expression
respiratory chain
matrix-assisted laser desorption-ionization mass spectrometry
metabolism
mitochondrion
neoplasm
pathology
proteomics
tumor cell line
Adenosine Triphosphate
Amides
Cell Line, Tumor
Energy Metabolism
Humans
Mitochondria
Neoplasms
Oxidative Stress
Proteomics
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
description Portoamides are cyclic peptides produced and released by the cyanobacterial strain Phormidium sp. presumably to interfere with other organisms in their ecosystems ("allelopathy"). Portoamides were previously demonstrated to have an antiproliferative effect on human lung carcinoma cells, but the underlying mechanism of this activity has not been described. In the present work, the effects of portoamides on proliferation were examined in eight human cancer cell lines and two non-carcinogenic cell lines, and major differences in sensitivities were observed. To generate hypotheses with regard to molecular mechanisms of action, quantitative proteomics using 2D gel electrophoresis and MALDI-TOF/TOF were performed on the colon carcinoma cell line HT-29. The expression of proteins involved in energy metabolism (mitochondrial respiratory chain and pentose phosphate pathway) was found to be affected. The hypothesis of altered energy metabolism was tested in further experiments. Exposure to portoamides resulted in reduced cellular ATP content, likely due to decreased mitochondrial energy production. Mitochondrial hyperpolarization and reduced mitochondrial reductive capacity was observed in treated cells. Furthermore, alterations in the expression of peroxiredoxins (PRDX4, PRDX6) and components of proteasome subunits (PSB4, PSA6) were observed in portoamide-treated cells, but these alterations were not associated with detectable increases in oxidative stress. We conclude that the cytotoxic activity of portoamides is associated with disturbance of energy metabolism, and alterations in mitochondrial structure and function. © 2017 Ribeiro et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
publishDate 2017
dc.date.none.fl_str_mv 2017
2017-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/120516
url https://hdl.handle.net/10216/120516
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 19326203
10.1371/journal.pone.0188817
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136193808433152